BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23643089)

  • 1. [Expression of PCAF in hepatocellular carcinoma and its clinical significance].
    Tuo H; Zheng X; Tu K; Zhou Z; Yao Y; Liu Q
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Mar; 29(3):297-300. PubMed ID: 23643089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low expression of CD112 is associated with poor overall survival in patients with hepatocellular carcinoma.
    Huang X; Qu P; Chen Y; Zhou X; Wu Y; Liu F; Wang D; Zhang J; An J
    Hum Pathol; 2014 Sep; 45(9):1944-50. PubMed ID: 25081539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
    Yang XR; Xu Y; Shi GM; Fan J; Zhou J; Ji Y; Sun HC; Qiu SJ; Yu B; Gao Q; He YZ; Qin WZ; Chen RX; Yang GH; Wu B; Lu Q; Wu ZQ; Tang ZY
    Clin Cancer Res; 2008 Jun; 14(12):3850-9. PubMed ID: 18559605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
    Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients].
    Zhou Q; Liang LJ; Peng BG; Zhen YY
    Ai Zheng; 2006 Nov; 25(11):1433-8. PubMed ID: 17094916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
    Lin SY; Pan HW; Liu SH; Jeng YM; Hu FC; Peng SY; Lai PL; Hsu HC
    Clin Cancer Res; 2008 Aug; 14(15):4814-20. PubMed ID: 18676753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
    Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
    J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma.
    He C; Xu J; Zhang J; Xie D; Ye H; Xiao Z; Cai M; Xu K; Zeng Y; Li H; Wang J
    Hum Pathol; 2012 Sep; 43(9):1425-35. PubMed ID: 22406368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas.
    Yu B; Yang X; Xu Y; Yao G; Shu H; Lin B; Hood L; Wang H; Yang S; Gu J; Fan J; Qin W
    J Hepatol; 2009 May; 50(5):948-57. PubMed ID: 19303159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone acetyltransferase PCAF accelerates apoptosis by repressing a GLI1/BCL2/BAX axis in hepatocellular carcinoma.
    Gai X; Tu K; Li C; Lu Z; Roberts LR; Zheng X
    Cell Death Dis; 2015 Apr; 6(4):e1712. PubMed ID: 25855960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and significance of tumor susceptibility gene 101 in hepatocellular carcinoma tissues].
    Gu RJ; Wang SC; Sun G; Zhuang BW; Liu DL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jul; 28(7):738-40. PubMed ID: 22768867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
    Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
    J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumor-infiltrating FoxP3+ Tregs are associated with CD34 expression and prognosis of hepatocellular carcinoma].
    Huang Y; Wang FM; Wang T; Wang YJ; Zhu ZY; Gao YT; DU Z
    Zhonghua Gan Zang Bing Za Zhi; 2012 Jan; 20(1):25-9. PubMed ID: 22464702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
    Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J
    Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P300/CBP-associated factor (PCAF) inhibits the growth of hepatocellular carcinoma by promoting cell autophagy.
    Jia YL; Xu M; Dou CW; Liu ZK; Xue YM; Yao BW; Ding LL; Tu KS; Zheng X; Liu QG
    Cell Death Dis; 2016 Oct; 7(10):e2400. PubMed ID: 27711074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of Raf kinase inhibitor protein and its significance in invasion and metastasis of hepatocellular carcinoma].
    Wu XH; Wang SX; Yang YJ; Li JK; Xu Z; Tang RF
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):358-62. PubMed ID: 21875465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on correlation of JAK/STAT signal pathway with progression and prognosis in hepatocellular carcinoma].
    Zhang B; Zhong DW; Wang QW; Miao XY; Dai WD; Liu C; Pan KH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Apr; 26(4):368-70, 373. PubMed ID: 20368117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelium-coated tumor clusters are associated with poor prognosis and micrometastasis of hepatocellular carcinoma after resection.
    Ding T; Xu J; Zhang Y; Guo RP; Wu WC; Zhang SD; Qian CN; Zheng L
    Cancer; 2011 Nov; 117(21):4878-89. PubMed ID: 21480209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.
    Yang LY; Tao YM; Ou DP; Wang W; Chang ZG; Wu F
    Clin Cancer Res; 2006 Oct; 12(19):5673-9. PubMed ID: 17020969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.